Commonwealth Equity Services LLC purchased a new stake in shares of Haleon plc (NYSE:HLN – Get Rating) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 466,049 shares of the company’s stock, valued at approximately $2,838,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. CKW Financial Group bought a new position in shares of Haleon in the third quarter valued at approximately $26,000. Whittier Trust Co. of Nevada Inc. bought a new position in Haleon in the 3rd quarter valued at $28,000. Assetmark Inc. acquired a new position in Haleon in the third quarter worth $29,000. Hudock Inc. bought a new stake in shares of Haleon during the third quarter worth $30,000. Finally, Benjamin F. Edwards & Company Inc. acquired a new stake in shares of Haleon in the third quarter valued at $33,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.
Haleon Trading Down 0.8 %
Shares of NYSE:HLN opened at $7.68 on Friday. The company has a 50 day moving average of $7.96 and a 200-day moving average of $7.05. Haleon plc has a one year low of $5.59 and a one year high of $8.50.
Haleon Dividend Announcement
Analyst Ratings Changes
Several brokerages recently issued reports on HLN. Investec began coverage on shares of Haleon in a research report on Thursday, February 23rd. They set a “sell” rating on the stock. Morgan Stanley upgraded shares of Haleon from an “equal weight” rating to an “overweight” rating in a research report on Friday, January 6th. Finally, Barclays raised their price target on shares of Haleon from GBX 360 ($4.33) to GBX 364 ($4.38) in a report on Tuesday, January 31st. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $364.00.
Haleon Profile
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.
Read More
- Get a free copy of the StockNews.com research report on Haleon (HLN)
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
